Empagliflozin
Showing 1 - 25 of 469
Empagliflozin in Cardiorenal Syndrome Type 1 Trial in Bangkok (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Empagliflozin in Cardiorenal Syndrome Type 1
- Empagliflozin 10 MG
- Placebo
-
Bangkok, Pathumwan, ThailandFaculty of Medicine, Chulalongkorn University
Sep 9, 2023
Cancer Trial (Empagliflozin 10 MG)
Not yet recruiting
- Cancer
- Empagliflozin 10 MG
- (no location specified)
Oct 22, 2023
Diabetic Neuropathy Peripheral Trial in Tanta (Empagliflozin 25 MG)
Active, not recruiting
- Diabetic Neuropathy Peripheral
- Empagliflozin 25 MG
-
Tanta, EgyptFaculty of pharmacy
Jul 28, 2023
Heart Failure, Hemodialysis Trial in Tehran (Empagliflozin10Mg Tab)
Recruiting
- Heart Failure
- Hemodialysis
- Empagliflozin10Mg Tab
-
Tehran, Iran, Islamic Republic ofNooshin Dalili
Jul 21, 2023
Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)
Completed
- Healthy
- Test Empagliflozin And Linagliptin Tablets
- Reference Empagliflozin And Linagliptin tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023
Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)
Recruiting
- Glycogen Storage Disease Type IB
- Empagliflozin
-
Shanghai, Shanghai, ChinaXinhua Hospital, Shanghai Jiao Tong University School of Medicin
Jul 17, 2023
Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Oct 30, 2023
End Stage Renal Disease on Dialysis Trial (Empagliflozin 25 mg vs Placebo, Empagliflozin 10 MG)
Not yet recruiting
- End Stage Renal Disease on Dialysis
- Empagliflozin 25 mg vs Placebo
- Empagliflozin 10 MG
- (no location specified)
Dec 22, 2022
Type 1 Diabetes Trial (Empagliflozin, Placebo)
Not yet recruiting
- Type 1 Diabetes
- Empagliflozin
- Placebo
- (no location specified)
Aug 31, 2023
Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,
Recruiting
- Glucose Metabolism Disorders
- +3 more
- Empagliflozin 10 MG
- Insulin+Metformin+DPP4 inhibitor (DPP4I)
-
Karachi, PakistanSINA Shireen Jinnah colony
Nov 28, 2023
Kidney Failure, Chronic, Heart Failure Trial in Jackson (Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing,
Not yet recruiting
- Kidney Failure, Chronic
- Heart Failure
- Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing
- Empagliflozin 10 mg daily dosing
-
Jackson, MississippiUniversity of Mississippi Medical Center
Jan 19, 2023
Diabetes, Kidney Transplant; Complications Trial (Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet)
Not yet recruiting
- Diabetes Mellitus
- Kidney Transplant; Complications
- Empagliflozin 25 MG
- Linagliptin 5 mg Oral Tablet
- (no location specified)
Oct 18, 2023
Polycystic Ovary Syndrome, Weight Gain, HbA1c Trial in Karachi (Empagliflozin 10 MG, MetFORMIN 500 Mg Oral Tablet)
Recruiting
- Polycystic Ovary Syndrome
- +2 more
- Empagliflozin 10 MG
- MetFORMIN 500 Mg Oral Tablet
-
Karachi, Sindh, PakistanSINA Yousuf Sb Goth
Nov 28, 2023
Cirrhosis, Liver Failure Trial (Empagliflozin 10 MG, Matching Placebo)
Not yet recruiting
- Cirrhosis
- Liver Failure
- Empagliflozin 10 MG
- Matching Placebo
- (no location specified)
Feb 2, 2023
Post-operative Atrial Fibrillation, CABG Trial in Tehran (Empagliflozin 10 MG, Placebo)
Recruiting
- Post-operative Atrial Fibrillation
- CABG
- Empagliflozin 10 MG
- Placebo
-
Tehran, Iran, Islamic Republic of
- +1 more
Nov 6, 2023
Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Shenyang (Empagliflozin 10 Mg)
Enrolling by invitation
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
- Empagliflozin 10 Mg
-
Shenyang, Liaoning, ChinaShengjing Hospital
Dec 22, 2022
Heart Failure Trial in New Haven (Empagliflozin 10 mg, Placebo)
Not yet recruiting
- Heart Failure
- Empagliflozin 10 mg
- Placebo
-
New Haven, Connecticut
- +1 more
Jan 9, 2023
Heart Failure With Reduced Ejection Fraction Trial in Alexandria (Empagliflozin 10 MG)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Empagliflozin 10 MG
-
Alexandria, EgyptAlexandria University
Mar 9, 2023
Non-Alcoholic Fatty Liver Disease, Type2diabetes Trial in Karachi (Empagliflozin 10 MG, Pioglitazone 15mg, Metformin)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Type2diabetes
- Empagliflozin 10 MG
- +2 more
-
Karachi, Sindh, PakistanMedical ICU, Jinnah Postgraduate Medical Centre
Jul 11, 2023
Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)
Not yet recruiting
- Kidney Transplant; Complications
- Diabetes Mellitus
- Empagliflozin 25 MG
- Linagliptin
- (no location specified)
Oct 18, 2023
Empagliflozin in Post AKI Stage 2-3 Trial in Thailand (Empagliflozin 10 MG, Placebo)
Recruiting
- Empagliflozin in Post AKI Stage 2-3
- Empagliflozin 10 MG
- Placebo
-
Nonthaburi, Mueang Nonthaburi District, ThailandCentral Chest Institute of Thailand
Oct 27, 2022
Comparative Effectiveness of Empagliflozin in the US
Active, not recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin
- +2 more
-
Boston, MassachusettsBringham Women Hospital
Jan 9, 2023
Ulcerative Colitis Trial in Shibin Al Kawm (Empagliflozin 10 MG, Placebo)
Recruiting
- Ulcerative Colitis
- Empagliflozin 10 MG
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Oct 25, 2022
Emp-Activity: Empagliflozin Functional Capacity
Not yet recruiting
- Heart Failure
- Empagliflozin
- (no location specified)
Aug 5, 2022
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics Trial (Empagliflozin,
Not yet recruiting
- Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
- Empagliflozin
- olanzapine
- (no location specified)
Jan 22, 2023